News from tapimmune inc

Mar 20, 2013, 09:00 ET

TapImmune Announces the Appointment of Sherry Grisewood to the Board of Directors

TapImmune Inc. (OTCQB: TPIV) has pleasure in announcing the appointment of Sherry Grisewood, CFA to the Board of Directors. She has over 25...

Mar 13, 2013, 09:00 ET

TapImmune Inc. to Present at the Florida Road Show Conference on March 14, 2013

 TapImmune Inc. ("TapImmune" or the "Company") (OTCQB: TPIV), an immunotherapy company focused on the development of novel peptide and...

Jan 22, 2013, 09:00 ET

Details of HER-2/neu Class I Antigen Licensed by TapImmune published in Journal of Immunology: Antigen is a naturally processed epitope for breast cancer vaccines.

 TapImmune Inc. (OTCBB: TPIV) is pleased to announce the January publication of a paper titled "Enzymatic Discovery of a HER-2/neu Epitope That...

Jan 09, 2013, 09:00 ET

Positive Interim Safety Analysis Achieved in Breast Cancer Patients Treated with HER2/neu Antigens

 TapImmune Inc. (OTCBB: TPIV) has announced that an interim safety analysis on the first five breast cancer patients treated with HER2/neu...

Organizations in the News

The organizations with the most activity in PR Newswire's News Room

Research and Markets
Analysts Review